Opinion
MISC. CASE NO. 16-mc-79
11-17-2016
RUTH BLACK v. TAKEDA PHARMACEUTICALS AMERICA, INC.; TAKEDA PHARMACEUTICALS U.S.A., INC. F/K/A TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.; TAKEDA PHARMACEUTICAL COMPANY LIMITED
JUDGE DOHERTY
MAGISTRATE JUDGE HANNA REPORT AND RECOMMENDATIONS ON UNOPPOSED MOTION FOR SETTLEMENT AS TO CLAIMS OF DECEDENT , DONALD NIX
This Court, having reviewed Plaintiffs' Unopposed Motion to Approve Settlement as to Claims of RUTH BLACK, as ADMINISTRATOR and Derivative Claimant; and RONALD NIX, MARY NIX, JOHN NIX, AND HARVEY NIX as Derivative Claimants and Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals U.S.A., Inc. (collectively "Takeda"), the parties having received due notice of and having had the opportunity to be heard, and this Court having considered all submissions made, I recommend to the Court that the Motion be
GRANTED and
The settlement by and between Plaintiffs, RUTH BLACK, as ADMINISTRATOR and Derivative Claimant; and RONALD NIX, MARY NIX, JOHN NIX, AND HARVEY NIX as Derivative Claimant individually and as legal heirs to the Estate of RUTH BLACK, deceased, and Takeda, as notice to the Court on November 16, 2016 be
APPROVED.
The Court has jurisdiction of this matter by virtue of the Plaintiffs participating in the Actos MDL Master Settlement Agreement.
ANY PARTY OBJECTING TO THIS RECOMMENDATION SHALL SUBMIT OBJECTIONS, IN WRITING, DIRECTLY TO JUDGE DOHERTY'S CHAMBERS - AND SHALL NOT FILE THE OBJECTION INTO THE RECORD - NO LATER THAN TEN (10) DAYS AFTER ENTRY OF THIS RECOMMENDATION.
If there is no objection within ten (10) days of the entry of this Recommendation, the Recommendation will become an Order.
This is DONE AND SIGNED in Lafayette, Louisiana, this 17th of November, 2016.
/s/_________
HONORABLE PATRICK J. HANNA
UNITED STATES MAGISTRATE JUDGE